Northern Trust Corp Immunic, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Immunic, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 264,968 shares of IMUX stock, worth $312,662. This represents 0.0% of its overall portfolio holdings.

Number of Shares

264,968

Previous 240,238 10.29%

Holding current value

$312,662

Previous $317,000 7.26%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.98 - $1.44 $24,235 - $35,611	24,730 Added 10.29%	264,968 $294,000
Q1 2024 May 14, 2024	BUY	$1.14 - $1.53 $86,410 - $115,972	75,799 Added 46.1%	240,238 $317,000
Q4 2023 Feb 13, 2024	BUY	$0.97 - $1.6 $52,598 - $86,760	54,225 Added 49.2%	164,439 $246,000
Q3 2023 Nov 13, 2023	SELL	$1.35 - $2.87 $504 - $1,073	-374 Reduced 0.34%	110,214 $162,000
Q2 2023 Aug 11, 2023	BUY	$1.33 - $2.51 $17,130 - $32,328	12,880 Added 13.18%	110,588 $277,000
Q1 2023 May 15, 2023	BUY	$1.35 - $2.87 $21,942 - $46,648	16,254 Added 19.95%	97,708 $145,000
Q4 2022 Feb 13, 2023	BUY	$1.13 - $10.8 $1,249 - $11,944	1,106 Added 1.38%	81,454 $114,000
Q3 2022 Nov 14, 2022	BUY	$3.0 - $5.49 $13,728 - $25,122	4,576 Added 6.04%	80,348 $254,000
Q2 2022 Aug 12, 2022	SELL	$3.13 - $12.25 $351,736 - $1.38 Million	-112,376 Reduced 59.73%	75,772 $263,000
Q1 2022 May 13, 2022	BUY	$9.54 - $14.26 $52,975 - $79,185	5,553 Added 3.04%	188,148 $2.13 Million
Q4 2021 Feb 08, 2022	BUY	$7.34 - $10.25 $5,343 - $7,462	728 Added 0.4%	182,595 $1.75 Million
Q3 2021 Nov 15, 2021	BUY	$8.05 - $13.29 $133,452 - $220,321	16,578 Added 10.03%	181,867 $1.61 Million
Q2 2021 Aug 13, 2021	BUY	$11.76 - $16.85 $764,776 - $1.1 Million	65,032 Added 64.87%	165,289 $2.03 Million
Q1 2021 May 12, 2021	SELL	$14.21 - $25.3 $239,950 - $427,215	-16,886 Reduced 14.41%	100,257 $1.6 Million
Q4 2020 Feb 11, 2021	SELL	$14.8 - $20.37 $75,095 - $103,357	-5,074 Reduced 4.15%	117,143 $1.79 Million
Q3 2020 Nov 16, 2020	BUY	$11.74 - $22.0 $487,198 - $912,978	41,499 Added 51.41%	122,217 $2.27 Million
Q2 2020 Aug 14, 2020	BUY	$5.67 - $15.86 $457,671 - $1.28 Million	80,718 New	80,718 $979,000

Others Institutions Holding IMUX

# of Institutions

Shares Held

56M

Call Options Held

4.7K

Put Options Held

311K

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $36.1M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Immunic, Inc. Transaction History